Haemonetics (HAE) Acquisitions (2010 - 2026)

Haemonetics' Acquisitions history runs 10 years deep, the most recent figure standing at $60.2 million for Q1 2026.

• In Q1 2026, Acquisitions changed N/A year-over-year to $60.2 million; the TTM figure through Mar 2026 stood at $60.2 million (down 60.12% YoY), while the FY2026 annual figure was $60.2 million, down 60.12% from the prior year.
• Acquisitions was $60.2 million for Q1 2026 at Haemonetics, up from $1.8 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $243.9 million in Q4 2023 to a low of $1.8 million in Q3 2024.
• Historically, Acquisitions has averaged $116.5 million across 4 years, with a median of $104.7 million in 2024.
• Biggest YoY gain for Acquisitions was 14.0% in 2022; the steepest drop was 14.0% in 2022.
• A 4-year view of Acquisitions shows it stood at $2.8 million in 2022, then soared by 8456.21% to $243.9 million in 2023, then slumped by 99.28% to $1.8 million in 2024, then soared by 3329.06% to $60.2 million in 2026.
• The last three Acquisitions figures came in at $60.2 million (Q1 2026), $1.8 million (Q3 2024), and $149.2 million (Q2 2024), per Business Quant data.